Fertility Preservation for the Young Breast Cancer Patient
- PMID: 26790670
- PMCID: PMC4880615
- DOI: 10.1245/s10434-015-5036-8
Fertility Preservation for the Young Breast Cancer Patient
Abstract
Background: The American Society of Clinical Oncology (ASCO) guidelines include incorporation of fertility preservation guidelines in the care of breast oncology patients. This study aimed to examine the baseline knowledge and preferences concerning fertility preservation among women of childbearing age with newly diagnosed breast cancer at the time of their initial visit to Memorial Sloan Kettering Cancer Center (MSKCC).
Methods: A questionnaire on reproductive history, fertility knowledge, and preservation options was administered to women 18-45 years of age with newly diagnosed breast cancer at MSKCC between May and September 2011.
Results: The inclusion criteria were met by 60 women eligible for analysis who had a median age of 40 years (range 20-45 years). The findings showed that 50 % of the women either desired children in the future or were unsure whether they wanted children, with 9 % reporting that they received information about fertility preservation options before their MSKCC visit. Women who had never been pregnant were more likely than those with prior pregnancies to consider having children in the future (p = 0.001) and to contemplate fertility preservation options both before (p = 0.001) and after (p = 0.0002) cancer treatment.
Conclusion: Early referral allows patients to take advantage of fertility preservation options while preventing delay in the initiation of systemic therapy. Referral by the breast surgical oncologist at the time of the initial visit has the potential to increase fertility knowledge because it appears that many women have not yet received fertility information at this early treatment stage.
Similar articles
-
Developing a referral system for fertility preservation among patients with newly diagnosed cancer.J Natl Compr Canc Netw. 2011 Nov;9(11):1219-25. doi: 10.6004/jnccn.2011.0102. J Natl Compr Canc Netw. 2011. PMID: 22056654
-
Experience of young women diagnosed with breast cancer who undergo fertility preservation consultation.Clin Breast Cancer. 2012 Apr;12(2):127-32. doi: 10.1016/j.clbc.2012.01.002. Clin Breast Cancer. 2012. PMID: 22444719
-
Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.Hum Reprod. 2017 Oct 1;32(10):2123-2129. doi: 10.1093/humrep/dex276. Hum Reprod. 2017. PMID: 28938748
-
Issues with Fertility in Young Women with Breast Cancer.Curr Oncol Rep. 2019 May 16;21(7):58. doi: 10.1007/s11912-019-0812-4. Curr Oncol Rep. 2019. PMID: 31098718 Review.
-
Current evidence supporting fertility and pregnancy among young survivors of breast cancer.J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):374-81. doi: 10.1111/1552-6909.12301. Epub 2014 Apr 1. J Obstet Gynecol Neonatal Nurs. 2014. PMID: 24689363 Review.
Cited by
-
Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer.J Adolesc Young Adult Oncol. 2017 Sep;6(3):429-434. doi: 10.1089/jayao.2017.0031. Epub 2017 Jul 7. J Adolesc Young Adult Oncol. 2017. PMID: 28686476 Free PMC article.
-
Decisions of young women with breast cancer regarding fertility preservation before cancer treatment and family building after treatment.J Cancer Surviv. 2025 Apr 23. doi: 10.1007/s11764-025-01809-1. Online ahead of print. J Cancer Surviv. 2025. PMID: 40266447
-
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?J Clin Med. 2022 Dec 6;11(23):7239. doi: 10.3390/jcm11237239. J Clin Med. 2022. PMID: 36498813 Free PMC article. Review.
-
Fertility preservation in post-pubescent female cancer patients: A practical guideline for clinicians.Mol Clin Oncol. 2018 Jan;8(1):153-158. doi: 10.3892/mco.2017.1486. Epub 2017 Nov 3. Mol Clin Oncol. 2018. PMID: 29387409 Free PMC article.
-
Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.Int J Mol Sci. 2020 Oct 21;21(20):7792. doi: 10.3390/ijms21207792. Int J Mol Sci. 2020. PMID: 33096794 Free PMC article. Review.
References
-
- Department of Health and Human Services. Centers for Disease Control and Prevention, and the National Cancer Institute. U.S. Cancer Statistics Working Group . United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. 2014.
-
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. - PubMed
-
- Toi M, Iwata H, Yamanaka T, et al. Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer. 2010;116(13):3112–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous